InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Nardo Christopher J., SVP, Développement. Officer active across 1 company, notably Dermata Therapeutics, Inc.. In total, 1 reports have been published. Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Christopher J. Nardo is the Senior Vice President of Development at Dermata Therapeutics, Inc. In this role, he is responsible for leading product development initiatives and research and development strategy. With a strong background in the pharmaceutical sector, he plays a key role in advancing the company's projects and innovating treatments.